"Borrhen" HER2/Chr17cen fluorescence in situ hybridization probe (unsterilized) - Taiwan Registration 4817eee127a3fbe1ff9260c69bed2a31
Access comprehensive regulatory information for "Borrhen" HER2/Chr17cen fluorescence in situ hybridization probe (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 4817eee127a3fbe1ff9260c69bed2a31 and manufactured by PLEXBIO CO., LTD.. The authorized representative in Taiwan is PLEXBIO CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
B Hematology, pathology, and genetics
B.1860 Immunopathological histochemistry reagents and kits
Domestic
Dates and Status
Jan 23, 2015
Jan 23, 2020
Dec 05, 2017
Cancellation Information
Logged out
่ช่ซ่จป้ท